Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pulmonary Arterial Hypertension
Related studies linked through entity extraction aliases.
Novel Screening Strategies for Scleroderma PAH
- Status
- COMPLETED
- Phase
- N/A
Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
- Status
- TERMINATED
- Phase
- PHASE1
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
- Status
- COMPLETED
- Phase
- PHASE3
Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005)
- Status
- COMPLETED
- Phase
- PHASE1
Beraprost-314d Added-on to Tyvaso® (BEAT)
- Status
- COMPLETED
- Phase
- PHASE3
National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- N/A
Resynchronisation Therapy of Right Ventricle in Pulmonary Arterial Hypertension
- Status
- UNKNOWN
- Phase
- NA
Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
(-)-Epicatechin and Pulmonary Arterial Hypertension
- Status
- WITHDRAWN
- Phase
- PHASE1
To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
- Status
- TERMINATED
- Phase
- N/A
Iron Status and Hypoxic Pulmonary Vascular Responses
- Status
- COMPLETED
- Phase
- NA
Clinical Study of Macitentan in Patients With PAH to Psychometrically Validate PAH-SYMPACT Instrument
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument
- Status
- COMPLETED
- Phase
- PHASE3
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
- Status
- TERMINATED
- Phase
- N/A
Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography
- Status
- COMPLETED
- Phase
- NA
Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
- Status
- UNKNOWN
- Phase
- PHASE2
Tyvaso Dosing and Titration Evaluation: TyTRATE Registry
- Status
- COMPLETED
- Phase
- N/A
A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)
- Status
- COMPLETED
- Phase
- PHASE1